Susquehanna Portfolio Strategies’s Inozyme Pharma INZY Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-260,713	Closed	-$1.04M	–	1075
2025 Q2	$1.04M	Buy	+260,713	New	+$646K	0.02%	500

Susquehanna Portfolio Strategies's INZY Position: Q3 2025 in Review

Susquehanna Portfolio Strategies sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 260,713 shares — an estimated $1.04M sold.

Susquehanna Portfolio Strategies first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $1.04M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Susquehanna Portfolio Strategies reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Susquehanna Portfolio Strategies sold 260,713 Inozyme Pharma shares in Q3 2025, an estimated $1.04M.
Susquehanna Portfolio Strategies first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Susquehanna Portfolio Strategies's Inozyme Pharma position peaked at $1.04M in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Susquehanna Portfolio Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.